Skip to main content

Evidence for a Modulated Receptor Mechanism of Calcium Channel Blockade

  • Chapter
Book cover Calcium Antagonists

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 39))

  • 24 Accesses

Abstract

A large body of evidence suggests that the action of local anesthetics and antiarrhythmic drugs on membrane sodium channels is modulated by the state of the channel. That is, the affinity of the drug for its receptor varies and depends on whether the channel is rested and available, activated and open (conducting), or closed and inactivated (1–4) (see Fig. 1). The modulated receptor hypothesis for the action of sodium channel blockers has provided explanations for such phenomena as the selective depression of conduction in ischemic myocardium, suppression of tachycardias, and the selective action of lidocaine on ventricular vs. atrial tissue (4).

This work was supported in part by NIH grants HL-21672, HL-17452, and HL-29552

An established Investigator of the American Heart Association

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hille B: Local anesthetics: Hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol (69): 497–515, 1977.

    Article  CAS  PubMed  Google Scholar 

  2. Hondeghem LM, Katzung BG: Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta (472): 373–398, 1977.

    Article  CAS  PubMed  Google Scholar 

  3. Hondeghem LM, Katzung BG: Test of a model of antiarrhythmic drug action. Effect of quinidine and lidocaine on myocardial conduction. Circulation (61): 1217–1224, 1980.

    Article  CAS  PubMed  Google Scholar 

  4. Hondeghem LM, Katzung BG: Antiarrhythmic agents: Modulated receptor mechanism of action of sodium and calcium channel blocking drugs. Annual Rev Pharmacol (in press), 1984.

    Google Scholar 

  5. Kawai C, Konishi T, Matsuyama E, Ohazaki H: Comparative effects of three calcium antagonists, diltiazem, verapamil, and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies. Circulation (63): 1035–1042, 1981.

    Article  CAS  PubMed  Google Scholar 

  6. Trautwein W, Pelzer D, McDonald TF, Osterrieder W: AQA 39, a new bradycardic agent which blocks myocardial calcium (Ca) channels in a frequency- and voltage-dependent manner. Naunyn-Schmiedeberg’s Arch Pharmacol (317): 228–232, 1981.

    Article  CAS  Google Scholar 

  7. Hescheler J, Pelzer, Trube G, Trautwein W: Does the organic calcium blocker D600 act from inside or outside the cardiac cell membrane? Pflugers Arch 393: 287–291, 1982.

    Article  CAS  PubMed  Google Scholar 

  8. Pelzer D, Trautwein W, McDonald TF: Calcium channel block and recovery from block in mammalian ventricular muscle treated with organic channel inhibitors. Pflugers Arch (394): 97–105, 1982.

    Article  CAS  PubMed  Google Scholar 

  9. Lee KS, Tsien RW: Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature (302): 790–794, 1983.

    Article  CAS  PubMed  Google Scholar 

  10. Kanaya S, Arlock P, Katzung BG, Hondeghem L: Diltiazem and verapamil preferentially block inactivated calcium channels. J Mol Cell Cardiol (15): 145–148, 1983.

    Article  CAS  PubMed  Google Scholar 

  11. Kass RS: Nisoldipine: a new, more selective calcium current blocker in cardiac Purkinje fibers. J Pharmacol Exp Therap (223): 446–456, 1982.

    CAS  Google Scholar 

  12. Colatsky TJ: Quinidine block of cardiac sodium channels is rate- and voltage-dependent. Biophys J (37): 343a, 1982.

    Google Scholar 

  13. Mason JW, Hondeghem LM, Katzung BG: Amiodarone blocks inactivated cardiac sodium channels. Pflugers Arch (396): 79–81, 1983.

    Article  CAS  PubMed  Google Scholar 

  14. Kass RS, Scheuer T: Slow inactivation of calcium channels in the cardiac Purkinje fiber. J Mol Cell Cardiol (14): 615–618, 1982.

    Article  CAS  PubMed  Google Scholar 

  15. Holck M, Thorens S, Haeusler G: Characterization of [3H]nifedipine binding sites in rabbit myocardium. Eur J Pharmacol 85: 305–315, 1982.

    Article  CAS  PubMed  Google Scholar 

  16. DePover A, Matlib MA, Lee SW, Dube GP, Grupp IL, Grupp G, Schwartz A: Specific binding of [3H]nitrendipine to membranes from coronary ar¬teries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazem. Biochem Biophys Res Comm (108): 110–117, 1982.

    Article  CAS  PubMed  Google Scholar 

  17. Godfraind T, Dieu D: The inhibition by flunarizine of the norepineph- rine-evoked contraction and calcium influx in rat aorta and mesenteric arteries. J Pharmacol Exp Therap (217): 510–515, 1981.

    CAS  Google Scholar 

  18. Jones AW: Vascular smooth muscle and alterations during hypertension. In: Bulbring E, Brading AF, Jones AW, Tomita T (eds) Smooth muscle: an assessment of current knowledge. University of Texas Press, Austin, 1981, pp 397–430.

    Google Scholar 

  19. Clusin WT, Bristow MR, Bain DS, Schroeder JS, Jaillon P, Brett P, Harrison DC: The effects of diltiazem and reduced serum calcium on is-chemic ventricular fibrillation in the dog. Circ Res (50): 518–526, 1982.

    Article  CAS  PubMed  Google Scholar 

  20. Weishaar RE, Bing RJ: The beneficial effect of a calcium channel blocker diltiazem, on the ischemic-reperfused heart. J Mol Cell ardiol (12): 993–1009, 1980.

    Article  CAS  Google Scholar 

  21. Bush LR, Romson JL, Ash JL, Lucchesi BR: Effects of diltiazem on extent of ultimate myocardial injury resulting from temporary coronary artery occlusion in dogs. J Cardiovasc Pharmacol (4): 285–296, 1982.

    Article  CAS  PubMed  Google Scholar 

  22. Clusin WT, Bristow MR, Karagueuzian HS, Katzung BG, Schroeder JS: Do calcium-dependent ionic currents mediate ischemic ventricular fibrillation? Am J Cardiol (49): 606–612, 1982.

    Article  CAS  PubMed  Google Scholar 

  23. El-Sherif N, Lazzara R: Reentrant ventricular arrhythmias in the late myocardial infarction period. Effect of verapamil and D600 and the role of the “slow channel”. Circulation (60): 605–615, 1979.

    Article  CAS  PubMed  Google Scholar 

  24. Yamaguchi I, Obayashi K, Mandel WJ: Electrophysiological effects of verapamil. Cardivasc Res (12): 597–608, 1982.

    Article  Google Scholar 

  25. Sheehan FH, Epstein SE: Effects of calcium channel blocking agents on reperfusion arrhythmias. Am Heart J (103): 973–977, 1982.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Martinus Nijhoff Publishing, Boston

About this chapter

Cite this chapter

Clarkson, C.W., Inazawa, M., Kanaya, S., Hondeghem, L.M., Katzung, B.G. (1984). Evidence for a Modulated Receptor Mechanism of Calcium Channel Blockade. In: Sperelakis, N., Caulfield, J.B. (eds) Calcium Antagonists. Developments in Cardiovascular Medicine, vol 39. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3810-9_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-3810-9_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-3812-3

  • Online ISBN: 978-1-4613-3810-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics